Medical Developments International Ltd Asset Resilience Ratio

Latest as of June 2025: 26.86%

Medical Developments International Ltd asset resilience ratio. Medical Developments International Ltd (MVP) has an Asset Resilience Ratio of 26.86% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See MVP defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

AU$17.84 Million

≈ $12.62 Million USD Cash + Short-term Investments

Total Assets

AU$66.40 Million

≈ $46.98 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Medical Developments International Ltd (2003–2025)

Asset resilience ratio of Medical Developments International Ltd from 2003 to 2025. This chart shows how Medical Developments International Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Medical Developments International Ltd for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Medical Developments International Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see MVP asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$17.84 Million	26.86%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$17.84 Million	26.86%

Asset Resilience Insights

Very High Liquidity: Medical Developments International Ltd maintains exceptional liquid asset reserves at 26.86% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Medical Developments International Ltd Industry Peers by Asset Resilience Ratio

Compare Medical Developments International Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Medical Developments International Ltd Asset Resilience Ratio by Year (2003–2025)

Medical Developments International Ltd asset resilience ratio by year from 2003 to 2025. The table below shows the annual Asset Resilience Ratio data for Medical Developments International Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	26.86%	AU$17.84 Million ≈ $12.62 Million	AU$66.40 Million ≈ $46.98 Million	+10.41pp
2024-06-30	16.46%	AU$9.73 Million ≈ $6.89 Million	AU$59.16 Million ≈ $41.86 Million	-6.07pp
2023-06-30	22.52%	AU$24.66 Million ≈ $17.45 Million	AU$109.49 Million ≈ $77.47 Million	+2.40pp
2022-06-30	20.12%	AU$20.40 Million ≈ $14.43 Million	AU$101.36 Million ≈ $71.72 Million	-16.09pp
2021-06-30	36.21%	AU$36.28 Million ≈ $25.67 Million	AU$100.17 Million ≈ $70.88 Million	+19.83pp
2020-06-30	16.39%	AU$15.54 Million ≈ $11.00 Million	AU$94.85 Million ≈ $67.11 Million	-13.82pp
2019-06-30	30.21%	AU$25.62 Million ≈ $18.13 Million	AU$84.80 Million ≈ $60.00 Million	+28.61pp
2018-06-30	1.60%	AU$794.00K ≈ $561.81K	AU$49.55 Million ≈ $35.06 Million	-2.45pp
2017-06-30	4.05%	AU$1.69 Million ≈ $1.20 Million	AU$41.76 Million ≈ $29.55 Million	+1.90pp
2003-06-30	2.15%	AU$250.00K ≈ $176.89K	AU$11.63 Million ≈ $8.23 Million	--

pp = percentage points

About Medical Developments International Ltd

AU:MVP Australia Drug Manufacturers - Specialty & Generic

Market Cap

$30.29 Million

AU$42.81 Million AUD

Market Cap Rank

#23534 Global

#878 in Australia

Share Price

AU$0.38

Change (1 day)

+2.70%

52-Week Range

AU$0.37 - AU$0.67

All Time High

AU$11.06